These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12423668)

  • 1. The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat.
    Bartsch T; Akerman S; Goadsby PJ
    Neuropharmacology; 2002 Nov; 43(6):991-8. PubMed ID: 12423668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices.
    Chiou LC; Fan SH; Guerrini R; Caló G
    Neuropharmacology; 2002 Feb; 42(2):246-52. PubMed ID: 11804621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The putative OP(4) antagonist, [Nphe(1)]nociceptin(1-13)NH(2), prevents the effects of nociceptin in neuropathic rats.
    Corradini L; Briscini L; Ongini E; Bertorelli R
    Brain Res; 2001 Jun; 905(1-2):127-33. PubMed ID: 11423087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nociceptin/orphanin FQ receptor ligands on blood pressure, heart rate, and plasma catecholamine concentrations in guinea pigs.
    Hashiba E; Hirota K; Kudo T; Calo' G; Guerrini R; Matsuki A
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):342-7. PubMed ID: 12690425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally administered nociceptin/orphanin FQ (N/OFQ) evokes bradycardia, hypotension, and diuresis in mice via activation of central N/OFQ peptide receptors.
    Burmeister MA; Kapusta DR
    J Pharmacol Exp Ther; 2007 Jul; 322(1):324-31. PubMed ID: 17452419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orphanin FQ/nociceptin and [Phe(1)Psi(CH(2)-NH)Gly(2)] nociceptin(1-13)-NH(2) stimulate gastric motor function in anaesthetized rats.
    Krowicki ZK; Kapusta DR; Hornby PJ
    Br J Pharmacol; 2000 Aug; 130(7):1639-45. PubMed ID: 10928969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.
    Fantin M; Fischetti C; Trapella C; Morari M
    Br J Pharmacol; 2007 Oct; 152(4):549-55. PubMed ID: 17618307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
    J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal effects of intracerebroventricularly injected nociceptin/orphaninFQ in rats.
    Broccardo M; Guerrini R; Petrella C; Improta G
    Peptides; 2004 Jun; 25(6):1013-20. PubMed ID: 15203249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of nociceptin/orphanin FQ and its receptor in electroacupuncture-produced anti-hyperalgesia in rats with peripheral inflammation.
    Fu X; Wang YQ; Wu GC
    Brain Res; 2006 Mar; 1078(1):212-8. PubMed ID: 16563360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.
    Hashimoto Y; Calo' G; Guerrini R; Smith G; Lambert DG
    Eur J Pharmacol; 2002 Aug; 449(1-2):17-22. PubMed ID: 12163101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.
    Marti M; Stocchi S; Paganini F; Mela F; De Risi C; Calo' G; Guerrini R; Barnes TA; Lambert DG; Beani L; Bianchi C; Morari M
    Br J Pharmacol; 2003 Jan; 138(1):91-8. PubMed ID: 12522077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
    J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function.
    Kapusta DR; Burmeister MA; Calo' G; Guerrini R; Gottlieb HB; Kenigs VA
    J Pharmacol Exp Ther; 2005 Aug; 314(2):643-51. PubMed ID: 15855356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central administration of Orphanin FQ inhibits GnRH secretion by ORL1 receptor in the median eminence of freely moving ovariectomized rats.
    An XF; He M; Feng Y; Feng H; Yu JY
    Neurosci Bull; 2009 Feb; 25(1):1-6. PubMed ID: 19190682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.